Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antifungal
Biotech
Pulmocide pulls ph. 3 antifungal trial over mortality rate
The British biotech is now performing a thorough review of the trial data to determine the future of its opelconazole program.
Darren Incorvaia
Jan 7, 2026 10:57am
Basilea pens collab with US biotech to develop antifungal
Jan 7, 2026 7:05am
Basilea secures $39M as part of BARDA antifungal funding plan
Jul 8, 2025 3:52am
Newfound compound kills multi-drug-resistant fungi
Mar 19, 2025 12:00pm
Basilea opts not to take MRSA antibiotic into clinic
Feb 18, 2025 4:08am
AI-discovered proteins kill bacteria, fungi infecting mice: study
Feb 7, 2025 2:11pm
